Lifeloc's patented EasyTab™ mouthpiece eliminates the "YUCK" factor associated with many breathalyzers.
Wheat Ridge, Colorado (PRWEB) December 14, 2012
According to the CDC, the Flu season has officially begun and predictions are that this season will be a bad one. Lifeloc Technologies, a leading manufacturer of personal and professional breathalyzers believes that breathalyzer manufacturers have paid insufficient attention to reducing the risk of disease spread in their breathalyzer mouthpiece designs.
Lifeloc urges consumers to avoid the purchase or use of personal breathalyzers that do not allow mouthpieces or (straws as they are often called) to be changed without having to touch the "wet" end of the mouthpiece. Flu can easily pass from one infected person to another through contact with saliva. And it goes without saying to never share mouthpieces.
For professional users, Lifeloc recommends similar care in selecting their breath analyzer equipment. Workplace Breath Tester users and Law Enforcement Alcohol Screener users have enough to worry about without concern about contracting a communicable disease through contact with the used end of breathalyzer mouthpieces or blow-back of exhaled air.
Self-proclaimed Germaphobe and Lifeloc Director of Product Management, Kelly Silverman, commented, "Users of professional breathalyzers can be exposed to several types of non-hygenic mouthpiece designs. Avoid breath alcohol testers that require the user to touch the "Yucky" end the mouthpiece and avoid mouthpieces that direct exhaled breath straight up into the air where saliva droplets can fall back onto the operator." She adds, "It's always a good idea to wash your hands frequently during the Flu season."
By design Lifeloc's patented EasyTab™ mouthpieces direct exhaled breath away from the operator and the built in eject mechanism eliminates touching the wet end of the mouthpiece. Recently Lifeloc has begun to use antimicrobial plastic in their Workplace breath analyzer line to further reduce the possible spread of bacteria and germs.
The information provided in this press release is informational purposes only and is not intended as medical advice.
This release includes statements that constitute “forward-looking statements” under the securities laws. Forward-looking statements often contain words such as “believe”, “expect,” “plans”, “strategy”, “prospects”, “estimate”, “project”, “target”, “anticipate”, “will”, “should”, “see,” “guidance”, “confident” and similar terms. Forward-looking statements may include, among other things, statements relating to future and estimated sales, earnings, cash flow, results of operations, uses of cash and other measures of financial performance. All forward-looking statements involve risks, uncertainties and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Risks and uncertainties include, without limitation, the effect of economic conditions in the markets in which we operate,the financial condition of our customers and suppliers; delays and disruption in delivery of materials and services from suppliers; potential intellectual property infringement by third parties; potential legal proceedings initiated against us; the effect of changes in tax, environmental and other laws and regulations and political conditions in states and countries in which we sell our products and other factors beyond our control. These forward-looking statements speak only as of the date of this release and we undertake no obligation to update or revise any forward-looking statements after we distribute this release. For additional information identifying factors that may cause actual results to vary materially from those stated in the forward-looking statements, see our reports on Forms 10-K, 10-Q and 8-K filed with the SEC from time to time, including, but not limited to, the information included in our Forms 10-K and 10-Q under the headings “Business”,“Risk Factors”,“Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Legal Proceedings” and in the notes to the financial statements included in our Forms 10-K and 10-Q.